A Monte Carlo model of detected singlet oxygen luminescence and photosensitizer fluorescence during ALA-PDT of skin

Singlet Oxygen (1O2) Luminescence Dosimetry (SOLD) and fluorescence photobleaching are being investigated as dosimetric tools for clinical PDT. Both have been applied during superficial ALA-PDT of normal skin and skin cancers. The interpretation of fluorescence and SOLD data is complicated by the non-uniform distribution and bleaching of PpIX and the absorption and scattering of light in the skin. The aim of the present work was to tackle these challenges using Monte Carlo (MC) simulations. Skin was modeled as a three-layer semi-infinite medium with uniform optical properties in each layer. The initial depth-dependent distribution of PpIX was an exponential decay and, after the delivery of each treatment fluence increment, standard photochemical reaction kinetics were used to update the distribution of sensitizer and reacted singlet oxygen. Oxygen depletion due to photochemical consumption or vascular shutdown was also incorporated in the model. The adjoint method was applied to calculate the PpIX fluorescence and 1270 nm singlet oxygen luminescence reaching the skin surface in each time increment. The time-resolved evolution of the fluorescence and cumulative SOLD signals during treatment were compared to the time-resolved volume-averaged distribution of reacted singlet oxygen in the dermis layer for typical clinical PDT conditions. Approximate linear relationships were observed over most of the treatment time.

[1]  D. Kessel,et al.  DIRECT DETECTION OF SINGLET OXYGEN SENSITIZED BY HAEMATOPORPHYRIN AND RELATED COMPOUNDS , 1986, Photochemistry and photobiology.

[2]  Ken Kang-Hsin Wang,et al.  A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. , 2006, Medical physics.

[3]  B. Wilson,et al.  Forward-adjoint fluorescence model: Monte Carlo integration and experimental validation. , 1997, Applied optics.

[4]  Thomas H Foster,et al.  Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas , 2008, Clinical Cancer Research.

[5]  Michael S Patterson,et al.  Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells ¶ , 2005, Photochemistry and photobiology.

[6]  L. Wang,et al.  Optimal beam size for light delivery to absorption-enhanced tumors buried in biological tissues and effect of multiple-beam delivery: a Monte Carlo study. , 1997, Applied optics.

[7]  Michael S Patterson,et al.  Direct Near-infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo¶ , 2002, Photochemistry and photobiology.

[8]  Eiji Kohno,et al.  Detection of Near Infrared Emission from Singlet Oxygen in PDT with an Experimental Tumor Bearing Mouse , 2001 .

[9]  B. Wilson,et al.  The physics, biophysics and technology of photodynamic therapy , 2008, Physics in medicine and biology.

[10]  Brian C. Wilson,et al.  Direct Near‐infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo ¶ , 2002 .

[11]  S. Mitra,et al.  Photodynamic therapy: Biophysical mechanisms and molecular responses , 2004 .

[12]  Henricus J C M Sterenborg,et al.  Quantitative Model Calculation of the Time-dependent Protoporphyrin IX Concentration in Normal Human Epidermis After Delivery of ALA by Passive Topical Application or Iontophoresis¶ , 2002, Photochemistry and photobiology.

[13]  Elena Salomatina,et al.  Optical properties of normal and cancerous human skin in the visible and near-infrared spectral range. , 2006, Journal of biomedical optics.

[14]  M W Berns,et al.  Dosimetry model for photodynamic therapy with topically administered photosensitizers , 1996, Lasers in surgery and medicine.

[15]  Antonio Pifferi,et al.  Accelerated Monte Carlo models to simulate fluorescence spectra from layered tissues. , 2003, Journal of the Optical Society of America. A, Optics, image science, and vision.

[16]  J. Hudson,et al.  An analysis of factors affecting tissue oxygen tension , 1964, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[17]  Ross W. Boyle,et al.  Photodynamic Therapy and the Development of Metal-Based Photosensitisers , 2008, Metal-based drugs.

[18]  Tayyaba Hasan,et al.  In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy. , 2008, Journal of biomedical optics.